Abstract
Purpose of the Review
Institution of a Simultaneous Liver Kidney (SLK) policy by the OPTN in 2016 represented the culmination of more than a decade of consensus conferences, public comments, and inter-society cooperation. The debates produced a multi-tiered proposal that established medical eligibility criteria for kidney allocation, a requirement for the regional sharing of a kidney to a MELD 35 medical eligible candidate and creation of a safety net for patients receiving a liver-alone transplant with subsequent kidney failure within the first post transplant year.
Recent Interventions
The stratifications and alterations represented the first time that eligibility requirements have been instituted for allocating a multi-organ combination that is not tracked by the Scientific Registry of Transplant Recipients (SRTR). The provisions for reporting and follow-up of the allocation alteration have been identified and will be reported at regular intervals to the OPTN for public release. Although there are multiple interventions to limit the kidney utilization to those candidates with true medical necessity, it is unknown how this will impact the overall distribution of the kidneys, especially with the safety net now being offered to candidates that would not have met medical eligibility at the time of their transplant. As SLK comprises over 10% of all liver transplants, the requirement change may be significant and would hopefully result in the more efficient use of kidneys without a negative impact on patient survival. Although utilization would be much better monitored, the outcome measures would still be lacking.
Summary
Even with this landmark change, review of the allocation process that presently favors allocating a kidney to a multi-organ transplant before allocation to a kidney-alone recipient is examined, especially as the prioritization affects pediatric candidates. It is hoped that advancements in this area would bring allocation policies into greater alignment with the intentions of the Final Rule legislation.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
OPTN Policy 5.10.C: optn.transplant.hrsa.org.
Malinchoc M, Kamath P, Gordon F, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71.
Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving towards evidence-based transplantation policy. Liver Transpl. 2002;8:851–8.
Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–6.
Formica RN. Simultaneous liver kidney transplantation. Curr Opin Nephrol Hypertens. 2016;25:577–82.
Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology. 2002;35:1179–85.
Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant. 2007;7:1702–9.
Fong TL, Khemichian S, Shah T, Hutchinson IV, Chou YW. Combined liver kidney transplant is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation. 2012;94:411–6.
Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transprant. 2008;8:2243–51.
Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006;6:2651–9.
Simpson N, Chou YW, Cicciarelli JC, Selby RR, Fonf TL. Comparison of renal graft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation. 2006;82:1298–303.
Schmitt TM, Kumer SC, Al-Osaimi A, et al. Combined liver-kidney transplantation in patients with renal failure outcomes in the MELD era. Eur Soc Organ Transplant. 2009;22:876–83.
Israni AK, Xiong H, Liu J, Salkowski N, Trotter JF, Snyder JJ, et al. Predicting end-stage renal disease after liver transplant. Am J Transplant. 2013;13:1782–92.
Ruebner R, Goldberg D, Abt PL, Bahirwani R, Levine M, Sawinski D, et al. Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant. 2012;12:2958–65.
Locke JL, Warren DS, Singer AL, et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective use of renal allografts. Transplantation. 2008;85:935–42.
Sharma P, Shu X, Schaubel DE, Sung RS, Magee JC. Propensity score based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction. Liver Transpl. 2016;22:71–9.
Campbell MS, Kotyar DS, Brensinger CM, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl. 2005;11(9):1022–5.
Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, et al. Transplantation: impact of pretransplant renal insufficiency. Lever Transpl. 2008;14:665–71.
Hmoud B, Yong-Fang K, Wiesner RH, Singal AK. Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation. Transplantation. 2015;99:823–8.
Sharma P, Goodrich NP, Zhang M, Guidinger MK, Schaubel DE, Merion RM. Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol. 2013;8(7):1135–42.
Brennan TV, Lunsford KE, Vagefi PA, Bostrom A, Ma M, Feng S. Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction. Clin Transpl. 2015 Jan;29(1):34–43.
Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation. 2004;78:1048–54.
Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, et al. Outcomes and native kidney recovery following simultaneous liver-kidney transplantation. Am J Transplant. 2012;12:2949–57.
Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12:2901–8.
• Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, et al. Simultaneous liver-kidney allocation policy: proposal to optimize appropriate utilization of scarce resources. Am J Transplant. 2016;16:758–66. This paper describes the background and discussions of the initial policy proposal that was circulated in 2015. The final policy was based on this framework.
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intrern Med. 2003;139:605.
Beben T, Rifkin DE. GFR estimating equations and liver disease. Adv Chronic Kidney Dis. 2015;22:337–42.
Sherman DS, Fish DN, Teitebaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41:269–78.
•• Asch WS, Bia MJ. New organ allocation system for combined liver-kidney transplants and the availability of kidneys for transplant to patients with stage 4–5 CKD. Clin J Am Soc Nephrol. 2017;12:848–52. Examines the potential implications of the new SLK policy. As there was no modeling data available from SRTR or within the UNOS database, the authors raise the issue of potential increases in SLK due to more medically eligible candidates or the increased utilization of the safety net.
Final Rule National Organ Transplant Act (NOTA) of 1984 (42 U.S.C. 273, et seq).
Stewart DE, Kucheryavaya AY, Klassen DK, Turgeon NA Formica RN, Aeder MI. Changes in deceased donor kidney transplantation one year after KAS implementation. Am J Transplant. 2016;16:1834–47.
Choudhury RA, Reese PP, Goldberg DS, Bloom RD, Sawinski DL, Abt PL. A paired analysis of multi-organ transplantation: Implications for allograft survival. Transplantation. 2017;101(2):368–76.
Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, et al. Avoiding futility in simultaneous liver-kidney transplantation: analysis of 331 consecutive patients listed for dual organ replacement. Ann Surg. 2017;265(5):1016–24.
Aeder M, Stewart D, Kucheryavaya A. UNOS data: unpublished.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on OPTN Policy
Rights and permissions
About this article
Cite this article
Aeder, M.I. Simultaneous Liver-Kidney Transplantation: Policy Update and the Challenges Ahead. Curr Transpl Rep 5, 130–138 (2018). https://doi.org/10.1007/s40472-018-0190-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40472-018-0190-0